These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 29983309

  • 41. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B, Drudge-Coates L, Ali S, Pati J, Nargund V, Ali E, Cheng L, Wells P.
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Healing of osteonecrosis of the jaw (ONJ) after discontinuation of denosumab in a patient with bone metastases of colorectal cancer: a case report and hypothesis.
    Ohga N, Yamazaki Y, Tsuboi K, Kitagawa Y.
    Quintessence Int; 2015; 46(7):621-6. PubMed ID: 25646168
    [Abstract] [Full Text] [Related]

  • 45. Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan.
    Liu FC, Luk KC, Chen YC.
    Osteoporos Int; 2023 Oct; 34(10):1729-1737. PubMed ID: 37326685
    [Abstract] [Full Text] [Related]

  • 46. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB, O'Ryan F.
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S, Hayashida S, Funahara M, Sakamoto Y, Kojima Y, Yanamoto S, Umeda M.
    PLoS One; 2018 Nov; 13(7):e0201343. PubMed ID: 30048523
    [Abstract] [Full Text] [Related]

  • 49. Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan.
    Kunihara T, Tohmori H, Tsukamoto M, Kobayashi M, Okumura T, Teramoto H, Hamasaki T, Yamasaki T, Nakagawa T, Okimoto N, Fujiwara S.
    Osteoporos Int; 2023 Jun; 34(6):1101-1109. PubMed ID: 37002373
    [Abstract] [Full Text] [Related]

  • 50. Denosumab-related osteonecrosis of the jaw: A retrospective study.
    Egloff-Juras C, Gallois A, Salleron J, Massard V, Dolivet G, Guillet J, Phulpin B.
    J Oral Pathol Med; 2018 Jan; 47(1):66-70. PubMed ID: 28977694
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK.
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study.
    Kajizono M, Sada H, Sugiura Y, Soga Y, Kitamura Y, Matsuoka J, Sendo T.
    Biol Pharm Bull; 2015 Jun; 38(12):1850-5. PubMed ID: 26632176
    [Abstract] [Full Text] [Related]

  • 58. Incidence of osteonecrosis of the jaw by the use of osteoclast inhibitors in patients with bone metastases: a retrospective cohort study.
    Chaurand-Lara J, Pacheco-Ruiz L, Trejo-Campos JL, Facio-Umaña JA, Mora-Pérez J.
    Cir Cir; 2019 Jun; 87(4):396-401. PubMed ID: 31264983
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Aggressive denosumab-related jaw necrosis - a case series.
    Badr M, Kyriakidou E, Atkins S, Harrison S.
    Br Dent J; 2017 Jul 07; 223(1):13-16. PubMed ID: 28684826
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.